177 related articles for article (PubMed ID: 15168802)
1. Chemokine mRNA levels in mononucleated cells of HIV-infected patients before and after initiation of PI- versus NNRTI-containing HAART.
Wasmuth JC; Nischalke HD; Jütte A; Fätkenheuer G; Salzberger B; Sauerbruch T; Spengler U; Rockstroh JK; Dumoulin FL
Antiviral Res; 2004 Mar; 61(3):207-12. PubMed ID: 15168802
[TBL] [Abstract][Full Text] [Related]
2. Semiquantitative analysis of intrahepatic CC-chemokine mRNas in chronic hepatitis C.
Nischalke HD; Nattermann J; Fischer HP; Sauerbruch T; Spengler U; Dumoulin FL
Mediators Inflamm; 2004 Dec; 13(5-6):357-9. PubMed ID: 15770052
[TBL] [Abstract][Full Text] [Related]
3. Impact of NNRTI compared to PI-based highly active antiretroviral therapy on CCR5 receptor expression, beta-chemokines and IL-16 secretion in HIV-1 infection.
Burton CT; Hardy GA; Sullivan AK; Nelson MR; Gazzard B; Gotch FM; Imami N
Clin Exp Immunol; 2002 Nov; 130(2):286-92. PubMed ID: 12390317
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of toll-like receptor 2 in mononuclear cells from HIV-infected patients induces chemokine responses: possible pathogenic consequences.
Heggelund L; Damås JK; Yndestad A; Holm AM; Mūller F; Lien E; Espevik T; Aukrust P; Frøland SS
Clin Exp Immunol; 2004 Oct; 138(1):116-21. PubMed ID: 15373913
[TBL] [Abstract][Full Text] [Related]
5. Divergent regulation of HIV-1 replication in PBMC of infected individuals by CC chemokines: suppression by RANTES, MIP-1alpha, and MCP-3, and enhancement by MCP-1.
Vicenzi E; Alfano M; Ghezzi S; Gatti A; Veglia F; Lazzarin A; Sozzani S; Mantovani A; Poli G
J Leukoc Biol; 2000 Sep; 68(3):405-12. PubMed ID: 10985258
[TBL] [Abstract][Full Text] [Related]
6. Effect of vitamin D3 on chemokine expression in pulmonary tuberculosis.
Selvaraj P; Harishankar M; Singh B; Banurekha VV; Jawahar MS
Cytokine; 2012 Oct; 60(1):212-9. PubMed ID: 22800603
[TBL] [Abstract][Full Text] [Related]
7. Circulating levels and ex vivo production of beta-chemokines, interferon gamma, and interleukin 2 in advanced human immunodeficiency virus type 1 infection: the effect of protease inhibitor therapy.
De Luca A; Giancola ML; Cingolani A; Ammassari A; Murri R; Antinori A
AIDS Res Hum Retroviruses; 2000 Jun; 16(9):835-43. PubMed ID: 10875609
[TBL] [Abstract][Full Text] [Related]
8. Lipid profiles for antiretroviral-naive patients starting PI- and NNRTI-based therapy in the Swiss HIV cohort study.
Young J; Weber R; Rickenbach M; Furrer H; Bernasconi E; Hirschel B; Tarr PE; Vernazza P; Battegay M; Bucher HC
Antivir Ther; 2005; 10(5):585-91. PubMed ID: 16152752
[TBL] [Abstract][Full Text] [Related]
9. Change in circulating levels of the chemokines macrophage inflammatory proteins 1 alpha and 11 beta, RANTES, monocyte chemotactic protein-1 and interleukin-16 following treatment of severely immunodeficient HIV-infected individuals with indinavir.
Bisset LR; Rothen M; Joller-Jemelka HI; Dubs RW; Grob PJ; Opravil M
AIDS; 1997 Mar; 11(4):485-91. PubMed ID: 9084796
[TBL] [Abstract][Full Text] [Related]
10. Increased MCP-1, RANTES, and MIP-1alpha in bronchoalveolar lavage fluid of allergic asthmatic patients.
Alam R; York J; Boyars M; Stafford S; Grant JA; Lee J; Forsythe P; Sim T; Ida N
Am J Respir Crit Care Med; 1996 Apr; 153(4 Pt 1):1398-404. PubMed ID: 8616572
[TBL] [Abstract][Full Text] [Related]
11. Sustained suppression of plasma HIV RNA is associated with an increase in the production of mitogen-induced MIP-1alpha and MIP-1beta.
Kumar D; Parato K; Kumar A; Sun E; Cameron DW; Angel JB
AIDS Res Hum Retroviruses; 1999 Aug; 15(12):1073-7. PubMed ID: 10461827
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the CD4 response to antiretroviral regimens in patients commencing therapy with low CD4 counts.
Waters L; Stebbing J; Jones R; Michailidis C; Sawleshwarkar S; Mandalia S; Bower M; Nelson M; Gazzard B
J Antimicrob Chemother; 2004 Aug; 54(2):503-7. PubMed ID: 15201230
[TBL] [Abstract][Full Text] [Related]
13. Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team.
Staszewski S; Morales-Ramirez J; Tashima KT; Rachlis A; Skiest D; Stanford J; Stryker R; Johnson P; Labriola DF; Farina D; Manion DJ; Ruiz NM
N Engl J Med; 1999 Dec; 341(25):1865-73. PubMed ID: 10601505
[TBL] [Abstract][Full Text] [Related]
14. CC and C chemokine expression in pulmonary sarcoidosis.
Petrek M; Kolek V; Szotkowská J; du Bois RM
Eur Respir J; 2002 Nov; 20(5):1206-12. PubMed ID: 12449175
[TBL] [Abstract][Full Text] [Related]
15. Lack of good correlation of serum CC-chemokine levels with human immunodeficiency virus-1 disease stage and response to treatment.
Ye P; Kazanjian P; Kunkel SL; Kirschner DE
J Lab Clin Med; 2004 May; 143(5):310-9. PubMed ID: 15122175
[TBL] [Abstract][Full Text] [Related]
16. Chemokine and chemokine receptor expression after combined anti-HIV-1 interleukin-2 therapy.
Blanco J; Cabrera C; Jou A; Ruiz L; Clotet B; Esté JA
AIDS; 1999 Apr; 13(5):547-55. PubMed ID: 10203379
[TBL] [Abstract][Full Text] [Related]
17. Detection and localization of chemokine gene expression in autoimmune thyroid disease.
Kemp EH; Metcalfe RA; Smith KA; Woodroofe MN; Watson PF; Weetman AP
Clin Endocrinol (Oxf); 2003 Aug; 59(2):207-13. PubMed ID: 12864798
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast expression of C-C chemokines in response to orthopaedic biomaterial particle challenge in vitro.
Yaszay B; Trindade MC; Lind M; Goodman SB; Smith RL
J Orthop Res; 2001 Sep; 19(5):970-6. PubMed ID: 11562149
[TBL] [Abstract][Full Text] [Related]
19. Highly active antiretroviral therapy normalizes the potential for MIP-1alpha production in HIV infection.
Carter LM; Peters BS; Ellis BA; Wolstencroft RA
J Infect; 2000 Nov; 41(3):252-5. PubMed ID: 11120614
[TBL] [Abstract][Full Text] [Related]
20. The limited infectability by R5 HIV of CD34(+) cells from thymus, cord, and peripheral blood and bone marrow is explained by their ability to produce beta-chemokines.
Majka M; Rozmyslowicz T; Ratajczak J; Dobrowsky A; Pietrzkowski Z; Gaulton GN; Janowska-Wieczorek A; Ratajczak MZ
Exp Hematol; 2000 Dec; 28(12):1334-42. PubMed ID: 11146155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
